Related Experiment Videos
[Clinical studies on sultamicillin in pediatrics]
T Sekiguchi1, M Miyazaki, M Nishimori
1Department of Pediatrics, Takamatsu Red Cross Hospital.
Insights
Sultamicillin (SBTPC) fine granule effectively treated pediatric bacterial infections, achieving excellent clinical responses and bacterial eradication in all 15 children. This antibiotic shows promise for various pediatric infections with minimal side effects.
Area of Science:
- Pediatric Infectious Diseases
- Pharmacology
- Clinical Microbiology
Context:
- Acute bacterial infections in children require effective and safe antibiotic options.
- Sultamicillin (SBTPC) is a prodrug of ampicillin and sulbactam, offering broad-spectrum activity.
- Assessing the efficacy and safety of fine granule formulations is crucial for pediatric compliance.
Purpose:
- To evaluate the clinical efficacy and safety of orally administered Sultamicillin (SBTPC) fine granule in pediatric patients.
- To determine the effectiveness of SBTPC in achieving clinical cure and bacterial eradication across various acute bacterial infections.
- To identify any adverse effects associated with SBTPC treatment in children.
Summary:
- Fifteen pediatric patients with diverse acute bacterial infections (pharyngitis, tonsillitis, bronchitis, UTI, pneumonia, lymphadenitis) received oral SBTPC fine granule.
- Excellent clinical responses and successful bacterial eradication were observed in all 15 patients.
- The only reported adverse event was loose stool in one patient, indicating a favorable safety profile.
Impact:
- Sultamicillin (SBTPC) fine granule demonstrates significant therapeutic value in treating a range of bacterial infections in pediatric populations.
- The study supports SBTPC as a viable and effective antibiotic option for pediatric infectious disease management.
- This formulation may improve treatment adherence and outcomes in children due to its ease of administration.
Abstract:
Sultamicillin (SBTPC) fine granule was given orally to 15 children with acute bacterial infections including 4 with acute pharyngitis, 5 with acute tonsillitis, 2 each with acute bronchitis and urinary tract infections, and 1 each with acute pneumonia and cervical purulent lymphadenitis. Good to excellent clinical responses were obtained in all of the 15 patients and bacterial eradication of all 4 strains found in these cases. Loose stool was observed in 1 case. From the above clinical results, it appears that SBTPC is a useful antibiotics for the treatment of pediatric patients with various bacterial infections.